The objectives of the studies described in this proposal are to compare the characteristics of several subtypes of neuronal nicotinic receptors and to determine how nicotine affects the number and function of these receptors. Neuronal nicotinic receptors are assembled from alpha and beta subunits, and mammalian brain expresses mRNA encoding at least 6 different alpha and 3 different beta subunits. Despite this potential diversity, the properties of only two subtypes of neuronal nicotinic receptors in mammalian brain have been relatively well-characterized. Two important reasons for this lack of information about other neuronal nicotinic receptor subtypes are that l) until recently the radiolabeled nicotinic ligands that were available could reliably measure only receptors that contained either alpha4 and beta2 subunits or alpha7 subunits, and 2) there were no mammalian cell models that expressed a single defined subtype of neuronal nicotinic receptor. The studies described in this proposal are designed to overcome these limitations. We will use [3H)epibatidine ([3H]E3), a new ligand with very high affinity (approximately 5pM - 1 nM) for several different subtypes of neuronal nicotinic receptors, and measurements of nicotinic receptor-mediated 86Rb+ efflux to compare the characteristics and the regulation of nicotinic receptors in existing clonal cell lines and new, stably transfected mammalian cell lines that express defined subtypes of neuronal nicotinic receptors.
The specific aims of this research are: 1) To compare the regulation of alpha4/beta2 nicotinic receptors in primary cultures of rat brain and in mammalian cell lines that stably express these receptors to the regulation of receptors in rat brain in vivo. 2) To characterize the pharmacological properties and the regulation of the two or more nicotinic receptor binding sites labeled by [3H]epibatidine in brain. 3) To compare the pharmacological properties and subunit composition of the non-alpha4 nicotinic receptors in rat PC12 cells, IMR-32 cells and SHSY-5Y cells. 4) To examine the regulation of the function and number of non-alpha4 nicotinic receptors. 5) To construct a library of mammalian cell lines stably transfected with combinations of at least two different neuronal nicotinic receptor subunit cDNA clones. 6) To use the stably transfected cells to study acute desensitization of each defined receptor subtype and to determine how each alpha and beta subunit influences acute desensitization. 7) To determine how chronic exposure to nicotine and other nicotinic drugs affects the regulation of the number and function of each defined receptor subtype.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA006486-09
Application #
2897814
Study Section
Special Emphasis Panel (SRCD (21))
Program Officer
Aigner, Thomas G
Project Start
1990-04-01
Project End
2001-03-31
Budget Start
1999-04-01
Budget End
2000-03-31
Support Year
9
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Georgetown University
Department
Pharmacology
Type
Schools of Dentistry
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Xiao, Yingxian; Abdrakhmanova, Galya R; Baydyuk, Maryna et al. (2009) Rat neuronal nicotinic acetylcholine receptors containing alpha7 subunit: pharmacological properties of ligand binding and function. Acta Pharmacol Sin 30:842-50
Xiao, Yingxian; Kellar, Kenneth J (2004) The comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells. J Pharmacol Exp Ther 310:98-107
Xiao, Yingxian; Baydyuk, Maryna; Wang, Haizhu Pearl et al. (2004) Pharmacology of the agonist binding sites of rat neuronal nicotinic receptor subtypes expressed in HEK 293 cells. Bioorg Med Chem Lett 14:1845-8
Wei, Zhi-Liang; Petukhov, Pavel A; Xiao, Yingxian et al. (2003) Synthesis, nicotinic acetylcholine receptor binding affinities, and molecular modeling of constrained epibatidine analogues. J Med Chem 46:921-4
Davila-Garcia, Martha I; Musachio, John L; Kellar, Kenneth J (2003) Chronic nicotine administration does not increase nicotinic receptors labeled by [125I]epibatidine in adrenal gland, superior cervical ganglia, pineal or retina. J Neurochem 85:1237-46
Avila, Amy M; Davila-Garcia, Martha I; Ascarrunz, Veronica S et al. (2003) Differential regulation of nicotinic acetylcholine receptors in PC12 cells by nicotine and nerve growth factor. Mol Pharmacol 64:974-86
Abdrakhmanova, Galya; Dorfman, Julia; Xiao, Yingxian et al. (2002) Protons enhance the gating kinetics of the alpha3/beta4 neuronal nicotinic acetylcholine receptor by increasing its apparent affinity to agonists. Mol Pharmacol 61:369-78
Meyer, E L; Xiao, Y; Kellar, K J (2001) Agonist regulation of rat alpha 3 beta 4 nicotinic acetylcholine receptors stably expressed in human embryonic kidney 293 cells. Mol Pharmacol 60:568-76
Xiao, Y; Smith, R D; Caruso, F S et al. (2001) Blockade of rat alpha3beta4 nicotinic receptor function by methadone, its metabolites, and structural analogs. J Pharmacol Exp Ther 299:366-71
Yeh, J J; Yasuda, R P; Davila-Garcia, M I et al. (2001) Neuronal nicotinic acetylcholine receptor alpha3 subunit protein in rat brain and sympathetic ganglion measured using a subunit-specific antibody: regional and ontogenic expression. J Neurochem 77:336-46

Showing the most recent 10 out of 25 publications